Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

UNITED GENE HIGH-TECH GROUP LIMITED

(Incorporated in the Cayman Islands and continued in Bermuda with limited liability)

(Stock Code: 399) UNUSUAL PRICE AND TRADING VOLUME MOVEMENTS

This announcement is made at the request of The Stock Exchange of Hong Kong Limited (the
"Stock Exchange").
The board of directors (the "Board") of United Gene High-Tech Group Limited (the "Company") has noted recent increases in the price and the trading volume of the shares of the Company. Having made such enquiry with respect to the Company as is reasonable in the circumstances, the Board wishes to state that it is not aware of any reason for such increases.
Save and except as disclosed in the announcement of the Company dated 28 January 2014, the Board confirms that it is not aware of any information which must be announced to avoid a false market in the Company's securities or of any inside information that needs to be disclosed under Part XIVA of the Securities and Futures Ordinance (Chapter 571 of the laws of Hong Kong).
This announcement is made by the order of the Board, the directors of which individually and jointly accept responsibility for the accuracy of this announcement.
By Order of the Board

United Gene High-Tech Group Limited Lee Nga Yan

Executive Director

Hong Kong, 28 January 2014
- 1 -

As at the date of this announcement, the Board comprises Ms. Jiang Nian (chairman & non-executive Director), M s. Lee Nga Yan ( executive Director), Dr. Guo Yi ( executive Director), Ms. Xiao Yan (non-executive Director), Ms. Wu Yanmin (non-executive Director), Ms. Chen Weijun (independent non-executive Director), Dr. Zhang Zhihong (independent non-executive Director) and M r. Wang Rongliang (independent non-executive Director).

-2-

distributed by